隆基股份、陽光電源漲停中標國家光伏平價項目訂單
格隆匯8月21日丨國家電投旗下中電國際遼寧朝陽500MW光伏平價項目公佈招標結果顯示,億晶光電(600537.SH)獨獲414MW組件訂單加上340MW的組件優先採購權,隆基股份(601012.SH)中標EPC總包,包含組件及逆變器採購權,陽光電源(300274.SZ)獲得約為133MW的組串式逆變器訂單,禾望電氣(603063.SH)中標集散式逆變器訂單。受消息刺激,隆基股份漲停,且創歷史新高價27.05元,陽光電源漲停,億晶光電漲超3%,禾望電氣漲超1%。(行情來源:富途證券)
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.